All Posts: cancer research
-
Celebrating National Postdoc Appreciation Week
Reiko Asano, PhD, RN Reiko Asano, PhD, RN, is a postdoc in the department of professional nursing practice studying palliative care in heart failure. Reiko was inspired to study cardiovascular disease after caring for patients suffering from high symptom burden and repeated hospitalizations. Alexandra Taraboletti, PhD Georgetown Lombardi Comprehensive Cancer Center’s Alexandra Taraboletti, PhD, is […]
Category: GUMC Stories
-
Revealing the Molecular Engine That Drives Pancreatic Cancer Provides Ways to Turn It Off
Category: News Release
-
Recognizing the Toll of Oral Damage From Graft-Versus-Host Disease After Stem Cell Transplant
Category: News Release
-
Georgetown Lombardi Receives Transformational NCI Grant to Support Community Outreach and Research
Category: News Release
-
Can Green Tea Prevent Liver Cancer? A Georgetown Lombardi Physician-Scientist Team Up to Find Out
Category: GUMC Stories
-
Over 200 Strong and $2.5 Million Later, Men’s Event Marks 20 Years Fighting Cancer
Category: GUMC Stories
-
Georgetown University’s Cancer Center Receives Coveted ‘Comprehensive Cancer Center’ Status from the National Cancer Institute
Category: News Release
-
How a Comprehensive Cancer Center Makes a Difference in Patient Care
(April 26, 2019) — After being diagnosed with chronic lymphocytic leukemia (CLL) in 2009, Geoff Grubbs’ search for an expert led him to medical oncologist Bruce Cheson, MD, head of hematology and director of hematology research at Georgetown Lombardi. That connection became indispensable years later when Grubbs developed an extremely rare complication from the disease. […]
Category: GUMC Stories
-
Going with Your Gut: Exploring the Microbiota’s Role in Colorectal Cancer Among the Young
(March 26, 2019) — When figures released by the American Cancer Society in 2017 showed a rise in colorectal cancer cases and deaths among young people, Benjamin Weinberg, MD, was alarmed, but not surprised. The young medical oncologist at Georgetown Lombardi Comprehensive Cancer Center is accustomed to treating men and women in their 60s and […]
Category: GUMC Stories
-
Georgetown-Led Study Leads to First FDA-Approved Drug in Decades to Improve Survival in Small Cell Lung Cancer
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (March 18, 2019) — The U.S. Food and Drug Administration’s approval today of atezolizumab (Tecentriq®, Genentech) in combination with chemotherapy (carboplatin and etoposide) for the initial treatment of extensive-stage small cell lung cancer (SCLC) marks the end of numerous failed attempts to improve survival for those with the deadly disease. “Atezolizumab, […]
Category: News Release